Bharat Biotech and Serum Institute of India have announced plans to ramp up production
Bharat Biotech also submitted to the Centre their production plan for the next four months. It said it can ramp up production to 7.8 crore doses by August
As many as 125 centres administering Covaxin to 18-44 age group are likely to be closed down by Wednesday as the Delhi government did not receive new stock of the vaccine till Tuesday evening
Adar Poonawalla noted that the company is making every effort to enhance production of Covishield amid the second wave of COVID in the country
The much-awaited programme of inoculation of those between 18 and 45 years began on May 1 but was hobbled in the absence of supplies.
The Finance Ministry has relaxed rules to allow advance payment without bank guarantee to help the vaccine makers ramp up production, according to people familiar with the matter